We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 276 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more first-time investments, than exits

New positions opened: 276 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8472,031 (+184)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+184
Holders Change %
+9.96%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
276
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
MS
1251
Madden Securities
Texas
$1.04M
ACM
1252
Azimuth Capital Management
Michigan
$1.04M
BFA
1253
Beaumont Financial Advisors
Massachusetts
$1.04M +$797K +1,700 +320%
CAN
1254
Claraphi Advisory Network
United States
$1.04M +$32.4K +69 +3%
PFS
1255
Prospera Financial Services
Texas
$1.03M +$956K +2,039 +1,228%
JCM
1256
JS Capital Management
New York
$1.02M +$1.03M +2,200 New
TA
1257
Tiedemann Advisors
New York
$1.02M +$22.5K +48 +2%
LCM
1258
LVM Capital Management
Michigan
$1.02M +$4.69K +10 +0.5%
SCM
1259
Shapiro Capital Management
Georgia
$1.02M
CCM
1260
Community Capital Management
Florida
$1.02M
HFM
1261
Harvest Fund Management
China
$1.01M -$267K -570 -21%
BHTS
1262
Bar Harbor Trust Services
Maine
$1.01M -$67K -143 -6%
Wealth Enhancement Advisory Services
1263
Wealth Enhancement Advisory Services
Minnesota
$1.01M +$942K +2,008 New
GCM
1264
Galibier Capital Management
Ontario, Canada
$1.01M -$108K -230 -10%
UH
1265
Unigestion Holding
Switzerland
$1.01M +$1.01M +2,164 New
PCM
1266
Pennsylvania Capital Management
Pennsylvania
$1.01M +$156K +333 +20%
BAM
1267
Blueshift Asset Management
New Jersey
$997K +$1M +2,141 New
CIAS
1268
Capital Investment Advisory Services
North Carolina
$996K +$79.2K +169 +9%
RFN
1269
RDA Financial Network
Iowa
$991K +$997K +2,127 New
TIAM2
1270
Tru Independence Asset Management 2
Oregon
$989K +$995K +2,123 New
PCG
1271
Private Capital Group
Connecticut
$988K +$7.03K +15 +0.7%
SCM
1272
SOL Capital Management
Maryland
$979K
FMLI
1273
Fukoku Mutual Life Insurance
Japan
$978K -$610K -1,300 -38%
NAM
1274
Nexpoint Asset Management
Texas
$978K
RA
1275
Rational Advisors
New York
$978K +$983K +2,097 +69,900%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 276 funds opened new TMO positions and 70 closed out — a net gain of 206 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,847 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 276 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +206 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.